Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech

In the Literature

  • Article

    Weekly Tirzepatide Increases the Rate of Resolution for MASH

    November 3, 2025

    CLINICAL QUESTION: Does tirzepatide improve the rate of resolution of Metabolic Dysfunction-Associated Steatohepatitis (MASH) or decrease the fibrosis stage in patients with steatohepatitis and...

  • Article

    New Picture Stimuli for the NIHSS Validated

    November 3, 2025

    CLINICAL QUESTION: Does an updated National Institutes of Health Stroke Scale (NIHSS) language assessment tool perform well in a sample of diverse, neurologically unimpaired English-speaking...

  • Article

    Comparing Efficacy and Safety Between Patients with AF Taking DOACs or Warfarin After a DOAC Failure

    November 3, 2025

    CLINICAL QUESTION: Is warfarin better as a second-line anticoagulant than another direct oral anticoagulant (DOAC) in patients with atrial-fibrillation-induced ischemic strokes after failure of a...

  • Article

    Beta-Blockers Didn’t Reduce Mortality After Acute MI in Patients with Preserved Ejection Fraction

    November 3, 2025

    CLINICAL QUESTION: Do beta-blockers still reduce mortality after acute myocardial infarction (MI) in the modern era of faster and better reperfusion strategies? BACKGROUND: Beta-blockers have...

  • Article

    iStopMM Risk Score Helps Predict Which MGUS Patients Need Bone Marrow Biopsy

    November 3, 2025

    CLINICAL QUESTION: Does my patient with a monoclonal protein and probable monoclonal gammopathy of undetermined significance (MGUS) need a bone marrow biopsy to rule out smoldering multiple myeloma...

  • Article

    Anticoagulation Safety in Patients with Cirrhosis and AF

    November 3, 2025

    CLINICAL QUESTION: Do patients with cirrhosis and AF who are treated with anticoagulation have increased adverse safety events compared with patients with cirrhosis and AF who are not treated with...

  • Article

    Timely Cessation of PPIs in Critically Ill Patients is Associated with Mortality and Morbidity Reduction

    November 3, 2025

    CLINICAL QUESTION: Does the timely cessation of proton pump inhibitors (PPIs) in critically ill patients impact morbidity and mortality compared to those who continue PPI therapy? BACKGROUND: PPIs...

  • Article

    Apixaban Versus Aspirin for Subclinical AF: Stroke Prevention and Bleeding Risk

    November 3, 2025

    CLINICAL QUESTION: Does apixaban reduce the risk of stroke or systemic embolism compared to aspirin in patients with subclinical atrial fibrillation and elevated stroke risk? BACKGROUND: Subclinical...

  • Article

    Octreotide LAR Reduced Transfusion Needs and Endoscopic Interventions in Angiodysplasia-Related Anemia

    November 3, 2025

    CLINICAL QUESTION: Does octreotide long-acting release (LAR) reduce transfusion requirements in patients with angiodysplasia-related anemia? BACKGROUND: Angiodysplasias frequently cause refractory...

  • Article

    Using AI/NLP to Improve Clinical Efficiency and Drive Patient-Centered Care in Cancer Research

    October 1, 2025

    CLINICAL QUESTION: Should clinicians use artificial intelligence with natural language processing (AI/NLP) to assess patient messages and review patient concerns to further develop meaningful, novel...

1 2 3 … 71Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences